Restless legs syndrome
Willis-Ekbom disease · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A sensorimotor disorder with an irresistible urge to move the legs, worse at rest and in the evening and relieved by movement, frequently disrupting sleep. Iron deficiency is a key reversible driver and alpha-2-delta ligands are now preferred first-line pharmacotherapy.
Red flags
- Augmentation on dopamine agonists
- New focal neurological signs (reconsider diagnosis)
- Severe refractory symptoms requiring opioids
- Suicidal ideation or impulse control disorder on dopamine agonists
- Underlying iron deficiency from occult bleeding
Assessment
Differential diagnosis
- Peripheral neuropathy
- Nocturnal leg cramps
- Akathisia (drug-induced)
- Peripheral vascular disease
- Arthritis or positional discomfort
- Periodic limb movement disorder
Investigations
- Serum ferritin and transferrin saturation (treat if ferritin <75 micrograms/L)
- Renal function (uraemia association)
- Medication review (antidepressants, antihistamines, dopamine blockers)
- Glucose/HbA1c and B12 if neuropathy suspected
- Pregnancy consideration (common and usually transient)
Management
- Confirm the four core features: urge to move, worse at rest, relieved by movement, evening predominance
- Check and replace iron, aiming ferritin above 75 micrograms/L even without anaemia
- Review and withdraw aggravating drugs (SSRIs, antihistamines, metoclopramide)
- Advise on sleep hygiene, reduced caffeine and alcohol
- For persistent symptoms, start an alpha-2-delta ligand as first-line
- Reserve dopamine agonists for selected cases given augmentation risk, at lowest dose
- Monitor closely for augmentation (earlier, more intense, spreading symptoms)
- Consider low-dose opioid for severe refractory disease under specialist care
- Reassess iron periodically
- Refer refractory or augmented cases to a specialist
Drugs & doses
Ferrous sulfate 325 mg PO daily (with vitamin C) or IV iron if oral fails/ferritin very low
Gabapentin 300 mg PO nocte titrated to 300-900 mg
Pregabalin 75 mg PO nocte titrated to 150-450 mg
Gabapentin enacarbil 600 mg PO daily
Pramipexole 0.125 mg PO nocte or ropinirole 0.25 mg PO nocte (second-line, augmentation risk)
Low-dose oxycodone or targinact for severe refractory cases (specialist)
Disposition
Primary care or outpatient neurology. Refer refractory or augmented cases to a sleep/movement specialist.
Complications & pitfalls
- Chronic sleep deprivation and daytime impairment
- Dopaminergic augmentation
- Impulse control disorders with dopamine agonists
- Depression and reduced quality of life
Exam pearls
- Check ferritin in every patient; iron repletion alone can resolve symptoms
- Alpha-2-delta ligands have replaced dopamine agonists as preferred first-line due to augmentation
- Augmentation (symptoms creeping earlier in the day) signals dopaminergic overtreatment
- Many common drugs (antidepressants, antihistamines) worsen RLS
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.